Key result
In isolated perfused rat hearts, the half-maximal AMPK activation (A0.5) was 1.8 ± 0.3 μM AMP despite high [ATP], suggesting reduced ATP antagonism of AMPK activation in vivo.
The study demonstrates that in the intact rat heart, AMPK is activated at low AMP concentrations despite high ATP levels, suggesting reduced ATP antagonism in vivo compared to in vitro models.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Frederich et al. (2002) studied this question. Bromo-octanoate and amino-oxyacetate vs. No inhibitor or inhibitors plus butyrate was evaluated on Relationship between AMPK activity and cytosolic [AMP]. In isolated perfused rat hearts, the half-maximal AMPK activation (A0.5) was 1.8 ± 0.3 μM AMP despite high [ATP], suggesting reduced ATP antagonism of AMPK activation in vivo.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: